Summary
1. The positive inotropic effects of the dihydropyridine calcium activator Bay K 8644 were studied in guinea-pig isolated contracting myocardium and human papillary muscle strips obtained from patients undergoing mitral valve replacement or cardiac transplantation. 2. Bay K 8644 produced a slowly developing, concentration-dependent positive inotropic response in all cardiac tissues studied. In guinea-pig papillary muscle, the increase in force of contraction was half-maximal at 3.9 × 10−8 mol/l and the maximal inotropic effect was comparable to that obtained with ouabain, dobutamine or calcium. The guinea-pig left atrium (EC50, 2.1 × 10−7 mol/l) was fivefold less sensitive than the papillary muscle. 3. The maximal inotropic response to dihydroouabain was significantly increased after preincubation with Bay K 8644 (1 × 10−6 mol/l) in papillary muscles from both guinea-pig and human. In guinea-pig papillary muscles, the maximal inotropic response to dobutamine was not changed by preincubation with Bay K 8644 whereas in human papillary muscle strips, Bay K 8644 increased the inotropic response to dobutamine. 4. Bay K 8644 increased force of contraction (EC50, 4 × 10−8 mol/l) in human papillary muscle strips from patients undergoing mitral valve replacement. However, the maximal inotropic response to Bay K 8644 was reduced to 32 ± 4.4% that of calcium (15 mmol/l) measured in the same muscle strips. 5. A further reduction in maximal inotropic response to Bay K 8644 to 13 ± 1.2% that of calcium (15 mmol/l) with no change in potency was measured in human papillary muscle strips taken from terminally failing hearts of cardiac transplant recipients. 6. There was a significant correlation between the preoperative left ventricular ejection fraction and the maximal inotropic response to Bay K 8644 in isolated human papillary muscle strips. 7. These results suggest that Bay K 8644 affects excitation-contraction coupling of cardiac muscle so as to increase the maximal inotropic effect of the digitalis glycosides. Further, the inotropic response of human myocardial tissue to calcium channel activator Bay K 8644 may be reduced in states of pathological heart function.
Similar content being viewed by others
References
Akera T (1986) The function of Na+, K+-ATPase and its importance for drug action. In: Erdmann E, Greeff K, Skou JC (eds) Cardiac glycosides 1785–1985. Steinkopff, Darmstadt, pp 19–25
Akera T, Brody TM (1985) Sodium ion and the cardiac actions of digitalis. Trends Pharmacol Sci 6:156–159
Allen DG, Eisner DA, Pirolo JS, Smith GL (1985) The relationship between intracellular calcium and contraction in calcium-over-loaded ferret papillary muscles. J Physiol (Lond) 364:169–182
Bean BP, Nowycky MC, Tsien RW (1984) β-Adrenergic modulation of calcium channels in frog ventricular myocardium. Nature 307:371–375
Brandt W, Reiter M, Seibel K (1972) “Supramaximal“ enhancement of the inotropic effect of noradrenaline by tyramine. Naunyn-Schmiedeberg's Arch Pharmacol 273:294–306
Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sagemann WS, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. New Engl J Med 307:205–211
Brown AM, Kunze DL, Yatani A (1984) The agonist effect of dihydropyridines on Ca channels. Nature 311:570–572
Brown L, Erdmann E (1985) Concentration-response curves of positive inotropic agents before and after ouabain pretreatment. Cardiovasc Res 19:288–298
Brown L, Lorenz B, Erdmann E (1986) Reduced positive inotropic effects in diseased human ventricular myocardium. Cardiovasc Res 20:516–520
Capasso JM, Malhotra A, Scheuer J, Sonnenblick EH (1986) Myocardial biochemical, contractile, and electrical performance after imposition of hypertension in young and old rats. Circ Res 58:445–460
Eisner DA, Valdeolmillos M, Lederer WJ, Cannel MB (1986) Electrophysiological effects of cardiac glycosides. In: Erdmann E, Greeff K, Skou JC (eds) Cardiac glycosides 1785–1985. Steinkopff, Darmstadt, pp 69–78
Endoh M, Yanagisawa T, Taira N, Blinks JR (1986) Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Circulation 73 (suppl III): III-117-III-133
Erdmann E, Schoner W (1974) Ouabain-receptor interactions in (Na+ + KOuabain-receptor interactions in (Na+ + K+)-ATPase preparations. IV. The molecular structure of different cardioactive steroids and other substances and their affinity to the glycoside receptor. Naunyn-Schmiedeberg's Arch Pharmacol 283:335–356
Erdmann E, Philipp G, Scholz H (1980) Cardiac glycoside receptor, (Na+ + K+)-ATPase activity and force of contraction in rat heart. Biochem Pharmacol 29:3219–3229
Fabiato A (1983) Calcium-induced release of calcium from the sarcoplasmic reticulum. Am J Physiol 245:C1-C14
Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP (1987) Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end stage heart failure. Circulation 75:331–339
Fleckenstein A (1977) Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann Rev Pharmacol Toxicol 17:149–166
Franckowiak G, Bechem M, Schramm M, Thomas G (1985) The optical isomeres of the 1,4-dihydropyridine Bay K 8644 show opposite effects on Ca channels. Eur J Pharmacol 114:223–226
Garcia AG, Sala F, Reig JA, ViniegraS, Frias J, Fonteriz R, Gandia L (1984) Dihydropyridine Bay K 8644 activates chromaffin cell calcium channels. Nature 309:69–71
Glossmann H, Ferry DR, Goll A, Striessnig J, Zernig G (1985) Calcium channels and calcium channel drugs: recent biochemical and biophysical findings. Arzneim Forsch 35:1917–1935
Godfraind T, Miller R, Wibo M (1986) Calcium antagonism and calcium entry blockade. Pharmacol Rev 38:321–416
Hess P, Lansman JB, Tsien RW (1984) Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature 311:538–544
Honerjäger P, Heiss A, Schaefer-Korting M, Schönsteiner G, Reiter M (1984) UD-CG 115 — a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 325:259–269
Ishii K, Taira N, Yanagisawa T (1985) Differential antagonism by Bay K 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle. Br J Pharmacol 84:577–584
Kenakin TP, Ferris R (1983) Effects of in vivo β-adrenoceptor down-regulation on cardiac responses to prenalterol and pirbuterol. J Cardiovasc Pharmacol 5:90–97
Kennedy RH, Seifen E (1985) Stimulation frequency alters the inotropic response of atrial muscle to Bay K 8644. Eur J Pharmacol 107:209–214
Kokubun S, Reuter H (1984) Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells. Proc Natl Acad Sci USA 81:4824–4827
Langer GA (1980) The role of calcium in the control of myocardial contractility: An update. J Mol Cell Cardiol 12:231–239
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193:265–275
McDonald TF (1982) The slow inward calcium current in the heart. Ann Rev Physiol 44:425–434
Millard RW, Grupp G, Grupp IL, DiSalvo J, DePover A, Schwartz A (1983) Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine and verapamil. Circ Res 52 (suppl 1):29–39
Morad M, Tung L (1983) Ionic events responsible for the cardiac resting and action potential. Am J Cardiol 49:584–594
Näbauer M, Brown L (1986) The calcium agonist Bay K 8644: Positive inotropy on isolated, contracting guinea pig and human myocardium. Naunyn-Schmiedeberg's Arch Pharmacol 332:R44
Reuter H (1967) The dependence of slow inward current in Purkinje fibres on the extracellular calcium concentration. J Physiol (Lond) 192:479–492
Reuter H, Scholz H (1977) The regulation of the calcium conductance of cardiac muscle by adrenaline. J Physiol (Lond) 264:49–62
Rogg H, Criscione L, Truog A, Meier M (1985) In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and Bay K 8644. J Cardiovasc Pharmacol 7 (suppl 6):S31-S37
Sanguinetti MC, Kass RS (1984) Regulation of cardiac calcium channel current and contractile activity by the dihydropyridine Bay K 8644 is voltage-dependent. J Mol Cell Cardiol 16:667–670
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672
Scholz H (1984) Inotropic drugs and their mechanism of action. J Am Coll Cardiol 4:389–397
Schoner W, von Ilberg C, Kramer R, Seubert W (1967) On the mechanism of Na+- and K+-stimulated hydrolysis of adenosine triphosphate. 1. Purification and properties of a Na+- and K+-activated ATPase from ox brain. Eur J Biochem 1:334–343
Schramm M, Thomas G, Towart R, Franckowiak G (1983a) Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature 303:535–537
Schramm M, Thomas G, Towart R, Franckowiak G (1983b) Activation of calcium channels by novel 1,4-dihydropyridines. Arzneim-Forsch 33:1268–1272
Schwartz A, Grupp IL, Grupp G, Williams JS, Vaghy PL (1984) Effects of dihydropyridine calcium channel modulators in the heart. Biochem Biophys Res Comm 125:386–394
Thomas G, Groß R, Schramm M (1984) Calcium channel modulation: ability to inhibit or promote calcium influx in the same dihydropyridine molecule. J Cardiovasc Pharmacol 6:1170–1176
Thomas G, Groß R, Pfitzer G, Rüegg LC (1985) The positive inotropic dihydropyridine Bay K 8644 does not affect calcium sensitivity or calcium release of skinned cardiac fibres. Naunyn-Schmiedeberg's Arch Pharmacol 328:378–381
Trautwein W, Cavalie MS (1985) Cardiac calcium channels and their control by neurotransmitters and drugs. J Am Coll Cardiol 6:1409–1416
Vaghy PL, Grupp IL, Grupp G, Schwartz A (1984) Effects of Bay K 8644, a dihydropyridine analog, on 3H-nitrendipine binding to canine cardiac sarcolemma and the relationship to a positive inotropic effect. Circ Res 55:549–553
Wada Y, Satoh K, Taira N (1985) Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog. Naunyn-Schmiedeberg's Arch Pharmacol 328:382–387
Wier WG, Yue DT (1985) The effects of 1,4-dihydropyridine type Ca+-channel antagonists and agonists on intracellular Ca2+ transients accompanying twitch contraction of heart muscle. In: Fleckenstein A, van Breemen C, Groß R, Hoffmeister F (eds) Cardiovascular effects of dihydropyridine-type calcium antagonists and agonists. Springer, Berlin Heidelberg, pp 188–194
Wilmshurst PT, Walker LM, Fry CH, Mounsey JP, Twort CHC, Williams BT, Davies MJ, Webb-Peploe MM (1984) Inotropic and vasodilator effects of amrinone on isolated human tissue. Cardiovasc Res 18:302–309
Williams JS, Grupp IL, Grupp G, Vaghy PL, Dumont L, Schwartz A (1985) Profile of the oppositely acting enantiomeres of the dihydropyridine 202–791 in cardiac preparations: receptor binding, electrophysiological, and pharmacological studies. Biochem Biophys Res Comm 131:13–21
Author information
Authors and Affiliations
Additional information
The human heart papillary muscles were provided by Prof. E. Kreuzer, Prof. B. Kemkes, Dr. C. Weinhold and their colleagues, Herzchirurgische Klinik der Universität, Klinikum Grosshadern, D-8000 München 70, Federal Republic of Germany
Send offprint requests to E. Erdmann
Rights and permissions
About this article
Cite this article
Näbauer, M., Brown, L. & Erdmann, E. Positive inotropic effects of the calcium channel activator Bay K 8644 on guinea-pig and human isolated myocardium. Naunyn-Schmiedeberg's Arch Pharmacol 337, 85–92 (1988). https://doi.org/10.1007/BF00169482
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169482